Pay in 4 interest-free payments of $7.13 Learn more
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
Several other GLP-1 drugs are FDA-approved to treat type 2 diabetes, each with its own dosing schedule and form: Trulicity (dulaglutide) : a once-weekly injectable GLP-1 receptor agonist
A randomized, double-blind, placebo-controlled phase 2 study comparing the efficacy and safety of tirzepatide versus placebo in 196 patients with nonalcoholic steatohepatitis (SYNERGY-NASH) with or without diabetes is currently underway and is estimated to complete in 2024
Making informed decisions up front can reduce risk, improve efficiency, and help ensure a smooth path to commercialization
Research-grade retatrutide available from peptide suppliers is synthesized by third-party manufacturers and is not the same material used in Eli Lilly clinical trials
The dosage and frequency can vary depending on individual needs and objectives, but common dosages range from 500 mg to 2,000 mg
US$ 27.67
US$ 24.26
US$ 20.88
US$ 28.29
.png)
US$ 22.38
